Upload
nijole
View
23
Download
0
Embed Size (px)
DESCRIPTION
Epidemiology and clinical relevance. 1. World (thousands) cases: 204 Deaths 125 Europe cases: 63 Deaths 40. 2. Age standardized mortality rates, UE. _____ all ages ………35-64 years. La Vecchia et al, Ann Oncol 2010. 3. - PowerPoint PPT Presentation
Citation preview
1
Epidemiology and clinical relevance
2
World (thousands) cases: 204 Deaths 125Europe cases: 63 Deaths 40
3La Vecchia et al, Ann Oncol 2010
Age standardized mortality rates, UE
_____ all ages………35-64 years
Temporal trends of incidence and mortality rates, Italy
4AIRTUM, Epidemiologia e prevenzione 2006
Incidence and mortality rates in strata of age, Italy
5AIRTUM, Epidemiologia e prevenzione 2006
6
High incidence
area
High/low incidence areas incidence ratio
Low incidence
area
Cervical cancer
Columbia 15 Israel
Breast cancer
Canada, Columbia Britannica
7 Israel, not Jewish women
Endometrial cancer
USA, California
30 Japan
Ovarian cancer
Denmark 6 Japan
Serous 40 percent of all ovarian cancers; most common ovarian cancer
Endometrioid 20 percent of all ovarian cancers; 15 percent of endometrioid carcinomas coexist withendometriosis; 40 percent bilateral
Mucinous 25 percent of all ovarian cancers; origin unclear; may occur in association withendometriosis; associated with pseudomyxoma peritonei
Main factors associated with ovarian cancer risk
Increased riskEarly menarche/late
menopauseEndometriosis
Estrogen replacement therapy
Family historyGenetic syndromes
High-fat dietLow parity
Decreased riskEarly menopause/late
menarcheMultiparity
HysterectomyLow-fat diet
Oral contraceptive use
9
Relative risk Attributable risk
Nulliparity 2.0 5
Menarche<11y and menopause >50y
1.8 10
OC use. (>24 months)
0.5 12
Familiarity 2.1 2
Histerectomy 0.7 3
10
HRT use and hystologic subtypes
Serous Mucinous Endometriosis
Risch et al., 1996 1.4 0.7 1.9
Purdie et al., 1999 2.6
Parazzini et al., 2001 1.3 1.4 1.5
11
Ron et al., 1987Shu et al., 1989Brinton et al., 1989Whittemore et al., 1992Harris et al., 1992Rossing et al., 1994Risch et al., 1994Franceschi et al., 1994Venn et al., 1995Purdie et al., 1995Shushan et al., 1996Parazzini et al., 1997Mosgaard et al., 1997
Published studies on the relation between fertility treatments and ovarian cancer risk
Glud et al., 1998Modan et al., 1998Nugent et al., 1998Cramer et al., 1998Parazzini et al., 1998Potashnik et al., 1999Venn et al., 1999Klip et al., 2000Ness et al., 2000Parazzini et al., 2001Goodman et al., 2001Ness et al., 2002Lerner geva 2010
12
Casi Controlli N. % N. % OR (95% CI)
Total No 1016 98.5% 2385 98.9% 1.0 yes 15 1.5% 26 1.1% 1.3 (0.7-2.5)
Nulliparae No 181 98.4% 370 97.1% 1.0 Yes 3 1.6% 11 2.9% 0.6 (0.1-2.0)
Parae No 835 98.6% 2015 99.3% 1.0 Yes 12 1.4% 15 0.7% 1.9 (0.9-4.1)
Parazzini et al., 2001
Fertility treatments od risk of ovarian cancer
13
Cases Controls Adj OR 95% C.I.
ClomipheneNo 892 1070 1.01-3 m 17 25 0.9 (0.5 - 1.7)4-12 16 29 0.8 (0.4 - 1.4)> 12 9 10 1.2 (0.5 - 3.0)
GonadotropinNo 916 1110 1.01-3m 10 10 1.5 (0.6 - 3.6)4-12 6 13 0.6 (0.2 - 1.6)> 12 3 1 4.5 (0.5 -
44.1)
Ness et al., 2002
Incidence of ovarian cancer among patents with endometrioiss and the general Swedish population
(Melin et al, 2006)
14
15
Diet and ovarian cancer
• Cases-controls studies have shown a positive association between fat consumption and risk of ovarian cancer
• Cases-controls studies have shown a negative association between fat vitamin A,C, E and risk of ovarian cancer
• The women Health Initiative Dietary Modification Randomized Controlled Study has shown a decreased risk of ovarian cancer after 4 years of low fat diet(Prentice et al, 2007)
grazie16